Epanova

Drug / Medication

A formulation of EPA + DHA free fatty acids (not ethyl esters), used in the Strength study. Designed for better absorption but potentially caused GI irritation, possibly contributing to the study's negative results.

Mentioned in 4 videos

Videos Mentioning Epanova

Dr. Bill Harris on the Omega-3 Index: Increasing Omega-3 to Promote Longevity & Transform Health

Dr. Bill Harris on the Omega-3 Index: Increasing Omega-3 to Promote Longevity & Transform Health

FoundMyFitness

A formulation of EPA + DHA free fatty acids (not ethyl esters), used in the Strength study. Designed for better absorption but potentially caused GI irritation, possibly contributing to the study's negative results.

#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology

#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology

Peter Attia MD

A free omega-3 fatty acid product containing both EPA and DHA, acquired by AstraZeneca, which failed to show efficacy in a clinical trial and was subsequently stopped.

#83 – Bill Harris, Ph.D.: Omega-3 fatty acids

#83 – Bill Harris, Ph.D.: Omega-3 fatty acids

Peter Attia MD

A drug from AstraZeneca containing EPA plus DHA in free fatty acid form, currently being studied in the STRENGTH trial for cardiovascular outcomes.

The Optimal Omega-3 Protocol for Heart, Brain, & Longevity

The Optimal Omega-3 Protocol for Heart, Brain, & Longevity

FoundMyFitness

An omega-3 fatty acid formulation in free fatty acid form that was investigated in the Strength trial. It was noted to be potentially harsh on the gut.